Ingredion CEO sells 9,958 shares in planned trade

Ingredion Inc President and CEO James P. Zallie reported an open-market sale of 9,958 shares of common stock on February 18, 2026.

Accepted by SEC EDGAR 02/19/2026 - 05:22 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Ingredion Inc President and CEO James P. Zallie reported an open-market sale of 9,958 shares of common stock on February 18, 2026. The shares were sold at an average price of $116.55 per share in a transaction classified as a sale in the open market or a private transaction.

According to the filing, the sale was executed under a Rule 10b5-1 trading plan adopted by Zallie on May 7, 2025, indicating it was pre-arranged. After this transaction, he directly owns 33,010.579 shares of Ingredion common stock.

Insider Trade Summary

Net Seller: 9,958 shares

Net Sell 1 txn

Insider Zallie James P.

Role President and CEO

Sold 9,958 shs ($1.16M)

Type	Security	Shares	Price	Value
Sale	Common Stock	9,958	$116.55	$1.16M
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 106,540.579 shares (Direct)

Footnotes (1)

1. F1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 7, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Ingredion (INGR) report for James P. Zallie?

Ingredion reported that President and CEO James P. Zallie sold 9,958 shares of common stock in an open-market transaction. The sale occurred on February 18, 2026 and was disclosed in a Form 4 insider trading report filed with regulators.

At what price did James P. Zallie sell Ingredion (INGR) shares?

James P. Zallie sold 9,958 Ingredion common shares at an average price of $116.55 per share. This reflects the weighted-average sale price reported for the open-market transaction executed on February 18, 2026 in the Form 4 filing.

How many Ingredion (INGR) shares does James P. Zallie own after the sale?

Following the reported sale, James P. Zallie directly owns 33,010.579 shares of Ingredion common stock. This post-transaction holding reflects his remaining direct ownership as shown in the Form 4 insider trading disclosure.

Was the Ingredion (INGR) CEO’s stock sale made under a Rule 10b5-1 plan?

Yes, the filing states the sales were made under a Rule 10b5-1 trading plan adopted by James P. Zallie on May 7, 2025. Such plans allow pre-scheduled trades to occur automatically, helping separate them from day-to-day market timing decisions.

What role does James P. Zallie hold at Ingredion (INGR)?

James P. Zallie is identified as both President and CEO of Ingredion Inc. His leadership position makes his stock transactions particularly relevant to investors, and therefore they are reported through Form 4 filings as required for company officers and directors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zallie James P.

(Last) (First) (Middle)

5 WESTBROOK CORPORATE CENTER

(Street)

WESTCHESTER IL 60154

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ingredion Inc [ INGR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/18/2026		S(1)		9,958	D	$116.55	33,010.579	D
Common Stock								73,530	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 7, 2025.

	Michael N. Levy, attorney-in-fact	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.